<DOC>
	<DOC>NCT01071902</DOC>
	<brief_summary>The purpose of this study is to determine if Moxidex otic solution is safe and effective in treating middle ear infections in patients with ear tubes.</brief_summary>
	<brief_title>Safety and Efficacy of Moxidex Otic</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>6 months to 12 years of age Ear tubes in one or both ears Ear drainage visible by parent/guardian Ear drainage less than 21 days Other protocoldefined inclusion criteria may apply Patients not otorrheafree for 7 or less following tympanostomy tube surgery Ear tube with antimicrobial activity; ear tube longer than 2.5mm Nontube otorrhea No otic surgery other than tube placement in the last year No menarchial females; no diabetic patients No patients with any disease or condition that would negatively affect the conduct of the study No patients taking any other systemic antimicrobial therapy during the study Patient must meet certain medication washouts to be eligible Analgesic use (other than acetaminophen) is not allowed Patients may not be predisposed to neurosensory hearing loss Other protocoldefined exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ear tubes</keyword>
	<keyword>ear drainage</keyword>
	<keyword>ear infection</keyword>
	<keyword>ear drops</keyword>
	<keyword>acute otitis media</keyword>
</DOC>